AeroVironment
AVAV
$190.89
+10.70%
AeroVironment, Inc. is a defense technology company operating in the Aerospace & Defense industry, supplying unmanned aircraft systems (UAS), tactical missile systems, and high-altitude pseudo-satellites primarily to U.S. Department of Defense agencies and allied international governments. The company is a recognized leader and key technology provider in the unmanned systems and counter-UAS (drone defense) markets, delivering integrated capabilities across air, land, sea, space, and cyber domains. The current investor narrative is dominated by a stark contrast between significant operational setbacks—including a major Q3 earnings miss, a large goodwill impairment charge, and the termination of a critical $1.7 billion Space Force contract—and a bullish long-term outlook fueled by a record backlog, its position as a leader in counter-drone technology, and a favorable political environment advocating for increased domestic defense spending on drone capabilities.…
AVAV
AeroVironment
$190.89
Related headlines
Investment Opinion: Should I buy AVAV Today?
Rating: Hold. The core thesis is that while AVAV possesses a compelling long-term strategic position in counter-drone technology and a strong balance sheet, near-term operational failures, cash burn, and extreme volatility demand a cautious stance, making it unsuitable for new investment until a clear turnaround is demonstrated.
The Hold rating is supported by four specific data points: 1) The valuation (PS of 5.17x) is high for a company with negative net income and FCF, 2) Revenue growth is anemic at 1.43% YoY in Q3 and showing sequential decline, 3) Profitability has collapsed with Q3 operating income at -$20.8M, and 4) The stock's 41.82% annual decline and position just 0.4% above its 52-week low reflect a market that has already priced in deep pessimism, limiting near-term downside but not providing a catalyst for upside.
The two biggest risks invalidating a future Buy thesis are persistent negative free cash flow and a failure to restore gross margins above 30%. This Hold would upgrade to a Buy only if the company reports two consecutive quarters of positive operating income and operating cash flow, signaling a sustainable operational turnaround. It would downgrade to a Sell if quarterly revenue falls below $350M or if the debt-to-equity ratio rises above 0.2 due to cash burn. Relative to its own history, the stock is fairly valued given the degraded fundamentals, but it remains overvalued compared to profitable defense peers.
Sign up to view all
AVAV 12-Month Price Forecast
The outlook for AVAV is bifurcated and highly dependent on execution over the next 2-3 quarters. The neutral stance reflects the high probability (50%) of a muddle-through base case where the stock recovers modestly from deeply oversold levels but lacks the fundamental catalyst for a sustained bull run. The substantial 25% probability assigned to the bear case acknowledges the real risk of further fundamental deterioration. The stance would upgrade to bullish on evidence of consecutive quarters of margin recovery and positive operating cash flow. It would turn bearish if the stock breaks below $135 and Q4 results show accelerating cash burn.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on AeroVironment's 12-month outlook, with a consensus price target around $248.16 and implied upside of +30.0% versus the current price.
Average Target
$248.16
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$153 - $248
Analyst target range
Insufficient analyst coverage data is available to provide a meaningful consensus view, as the provided analyst data only includes estimates from a single source. This limited coverage typically indicates the stock is a mid-cap name with a specialized business model that may not be on the radar of all major investment banks, which can lead to higher volatility and less efficient price discovery due to lower institutional scrutiny and trading liquidity. The available institutional ratings from March 2026 show a pattern of reiterated bullish calls from multiple firms (e.g., Buy from Jefferies, Stifel, Needham; Outperform from Baird, RBC) immediately following the disappointing Q3 earnings, suggesting analysts are looking through the near-term impairments toward the record backlog and counter-drone leadership; however, without a published consensus target price or distribution, the strength and conviction behind this bullish sentiment cannot be quantitatively assessed, leaving investors to weigh the qualitative analyst optimism against the stark quantitative challenges presented in the financials.
Bulls vs Bears: AVAV Investment Factors
The investment debate for AVAV is a stark battle between a catastrophic near-term operational reality and a promising long-term strategic position. The bear case currently holds stronger quantitative evidence, anchored by the severe Q3 earnings miss, cash burn, margin collapse, and relentless stock price decline. The bull case is largely qualitative and forward-looking, relying on analyst faith in the record backlog and counter-drone leadership. The single most important tension is whether the company's strong balance sheet and market position can provide enough runway to convert its promising backlog into profitable, cash-generating execution before investor patience is exhausted. The resolution of this operational turnaround is the key to the thesis.
Bullish
- Record Backlog & Counter-Drone Leadership: Analysts cite a record backlog and the company's position as a leader in the critical counter-UAS (drone defense) market as a key long-term catalyst. This is supported by recent news highlighting concrete government contracts and a favorable political environment for domestic drone spending.
- Strong Balance Sheet with Low Debt: The company maintains a robust liquidity position with a current ratio of 3.52 and a very low debt-to-equity ratio of 0.073. This provides significant financial flexibility to navigate near-term operational challenges and invest in growth.
- Valuation at Multi-Year Low: The stock trades at a trailing PS ratio of 5.17x, near the lower end of its multi-year historical range (from 13.91x to 33.27x). This suggests substantial pessimism is already priced in, leaving room for multiple expansion on any positive fundamental development.
- Analyst Sentiment Remains Bullish: Despite the Q3 miss, institutional analysts from firms like Jefferies, Stifel, and Needham reiterated Buy/Outperform ratings in March 2026. This indicates professional conviction in the long-term thesis looking through near-term impairments.
Bearish
- Severe Profitability & Cash Flow Collapse: Q3 FY2026 net income was -$156.6M, driven by a $164.4M goodwill impairment. Even adjusting for this, operating income was -$20.8M, and trailing twelve-month free cash flow is deeply negative at -$195.3M, indicating the company is burning cash.
- Revenue Volatility & Contract Loss: Q3 revenue of $408.0M grew only 1.43% YoY and declined sequentially from $472.5M in Q2. This volatility is compounded by the termination of a critical $1.7 billion U.S. Space Force contract, raising execution and visibility concerns.
- Gross Margin Compression: Q3 gross margin collapsed to 17.05%, a severe drop from the trailing gross margin of 39.35%. This indicates significant operational pressure and cost issues in the recent quarter that overshadow the company's historical profitability profile.
- Extreme Price Downtrend & Underperformance: The stock is in a severe downtrend, down 25.01% over the past month and 25.89% over three months, drastically underperforming the SPY's +15.8% 3-month return. This reflects intense company-specific selling pressure, not just broad market conditions.
AVAV Technical Analysis
The prevailing price trend is a severe and sustained downtrend, with the stock down 41.82% over the past year and currently trading near the absolute bottom of its 52-week range, at approximately $136.68 versus a 52-week high of $417.86 and a low of $135.2. This positioning, just 0.4% above the 52-week low, signals the stock is in deeply oversold territory, which could represent a potential value opportunity but also reflects intense selling pressure and fundamental concerns that must be resolved before any sustained recovery. Recent momentum is profoundly negative and accelerating the longer-term decline, with the stock down 25.01% over the past month and 25.89% over the past three months; this sharp short-term underperformance, especially against a market (SPY) that is up 15.8% over three months, indicates severe company-specific issues are driving the sell-off, not just broader market conditions. Key technical support is the 52-week low of $135.2, a breach of which could trigger further algorithmic selling, while major resistance lies far above near the 52-week high of $417.86; the stock's beta of 1.361 confirms it is 36% more volatile than the market, which amplifies both downside risk and potential upside during a recovery, demanding careful risk management for any position.
Beta
1.40
1.40x market volatility
Max Drawdown
-66.7%
Largest decline past year
52-Week Range
$135-$418
Price range past year
Annual Return
-22.5%
Cumulative gain past year
| Period | AVAV Return | S&P 500 |
|---|---|---|
| 1m | -6.6% | -1.9% |
| 3m | +3.5% | +13.6% |
| 6m | -25.5% | +9.0% |
| 1y | -22.5% | +20.0% |
| ytd | -25.5% | +9.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AVAV Fundamental Analysis
Revenue trajectory shows significant volatility and recent pressure, with Q3 FY2026 revenue of $408.0 million representing only a 1.43% year-over-year growth; however, examining sequential quarters reveals a troubling pattern, as revenue declined from $472.5 million in Q2 to $408.0 million in Q3, indicating potential execution or contract timing issues that are overshadowing the modest annual growth. Profitability has collapsed into deep losses, with Q3 net income at -$156.6 million and a gross margin of just 17.05%, a severe compression from the 39.35% trailing gross margin; this margin collapse is primarily driven by a massive $164.4 million goodwill impairment charge and other one-time items, but even adjusting for that, the operating income was -$20.8 million, reflecting operational challenges and compressed margins in the recent quarter. The balance sheet and cash flow situation is mixed, with a strong liquidity position indicated by a current ratio of 3.52 and a very low debt-to-equity ratio of 0.073, providing financial flexibility; however, trailing twelve-month free cash flow is deeply negative at -$195.3 million, and Q3 operating cash flow was -$5.1 million, indicating the company is currently consuming, not generating, cash to fund operations, which elevates financial risk despite the low debt burden.
Quarterly Revenue
$408045000.0B
2026-01
Revenue YoY Growth
+1.43%
YoY Comparison
Gross Margin
+0.17%
Latest Quarter
Free Cash Flow
$-195302000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AVAV Overvalued?
Given the company's negative net income in the most recent quarter, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is elevated at 5.17x, while the forward-looking metric, EV-to-Sales, is 4.54x; the modest discount of the forward multiple suggests the market expects only slight sales growth or margin improvement, not a dramatic recovery. Compared to industry averages, specific data is not available in the provided dataset, preventing a quantified peer comparison; however, a PS ratio above 5x for a defense contractor experiencing significant earnings volatility and cash burn could be considered rich unless justified by exceptional growth prospects or a unique technological moat, which the current fundamentals do not clearly support. Historically, the stock's own PS ratio has fluctuated wildly, reaching as high as 33.27x in Q3 FY2026 (per historical ratios data) and as low as 13.91x in Q4 FY2023; the current PS of 5.17x sits near the lower end of this multi-year range, suggesting the market has already priced in substantial pessimism, leaving room for multiple expansion if the company can demonstrate a credible path to restoring profitability and cash flow.
PE
-36.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -820x~33224x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-32.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and immediate. The company reported a net loss of -$156.6M in Q3 FY2026, with a gross margin compression to 17.05% from a trailing 39.35%. More critically, trailing twelve-month free cash flow is -$195.3M, indicating the business is consuming cash to fund operations despite a low debt-to-equity ratio of 0.073. Revenue concentration risk is highlighted by the termination of a single $1.7B Space Force contract, and sequential revenue decline from Q2 to Q3 suggests potential execution or contract timing issues that could persist.
Market & Competitive Risks stem from its rich valuation amidst weak fundamentals and high volatility. With a trailing PS ratio of 5.17x and negative earnings, the stock is vulnerable to multiple compression if growth fails to materialize. The high beta of 1.361 confirms it is 36% more volatile than the market, amplifying downside during sector rotations or risk-off periods. Competitive disruption is a constant threat in defense tech, as highlighted by the successful $320M IPO of drone maker AEVEX, which could divert investor capital and attention.
The Worst-Case Scenario involves a failure to stabilize operations, leading to continued cash burn, further contract losses, and a breach of investor confidence. This could trigger a downward spiral where the stock breaks its key technical support at the 52-week low of $135.2. Given the stock's 66.65% max drawdown and current price of $136.68, a realistic adverse scenario could see a decline of 20-30% from here, revisiting levels near $100, representing a loss of over -25% for current investors. This would be catalyzed by another earnings miss, guidance reduction, or a significant backlog cancellation.
FAQ
The key risks, in order of severity, are: 1) Financial Risk: Sustained cash burn (-$195.3M TTM FCF) could erode the strong balance sheet despite low debt. 2) Operational Risk: Failure to restore profitability, as seen in Q3 operating income of -$20.8M and gross margin collapse to 17.05%. 3) Execution Risk: Volatile and declining sequential revenue, compounded by the loss of a major $1.7B contract, raises doubts about management's ability to convert backlog. 4) Market Risk: The stock's high beta of 1.361 makes it 36% more volatile than the market, amplifying losses during downturns.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $180 and $220 as it stabilizes from oversold conditions without a major catalyst. The Bull Case (25% probability) targets $300-$350 on successful backlog conversion and margin recovery. The Bear Case (25% probability) warns of a drop to $100-$135 if operational deterioration continues. The most likely outcome is the Base Case, which assumes the company stops the bleeding but fails to quickly reignite high growth, leading to a modest recovery from current levels.
AVAV is fairly valued relative to its current broken fundamentals but overvalued relative to profitable peers. The trailing Price-to-Sales ratio of 5.17x is at the low end of its own historical range (13.91x - 33.27x), suggesting the market has priced in significant bad news. However, for a company with negative net income and free cash flow of -$195.3M, any sales multiple is rich unless justified by hyper-growth, which the 1.43% YoY revenue increase does not support. The valuation implies the market is paying for future promise, not current performance.
AVAV is not a good buy for most investors at this time. While the stock is deeply oversold and boasts a strong strategic position in counter-drone technology, the near-term fundamentals are severely impaired, with negative earnings, cash burn, and volatile revenue. The 25% upside in the base case to ~$200 is outweighed by a 25% probability of a further decline to $100-$135. It could become a good buy for speculative investors only after the company demonstrates a clear turnaround, evidenced by two consecutive quarters of positive operating cash flow and margin recovery.
AVAV is unsuitable for short-term trading due to its high volatility (beta 1.361) and lack of near-term catalysts; it is a value trap for traders. It is only suitable for a long-term (3-5 year) investment horizon by investors who believe in the long-term drone and counter-drone thesis and are willing to endure extreme volatility while waiting for a multi-year operational turnaround. There is no dividend to provide income during the wait. A minimum holding period of 18-24 months is suggested to see if the turnaround plan gains traction.